[泼尼松龙治疗弥散性硬化症患者临床及免疫学指标的变化]。

Vrachebnoe delo Pub Date : 1991-12-01

A A Iarosh, A M Tiazhkorob, M M Prokopiv, S A Kanevskaia, I K Zhovnir

{"title":"[泼尼松龙治疗弥散性硬化症患者临床及免疫学指标的变化]。","authors":"A A Iarosh, A M Tiazhkorob, M M Prokopiv, S A Kanevskaia, I K Zhovnir","doi":"","DOIUrl":null,"url":null,"abstract":"The authors examined clinically and immunologically 60 patients with multiple sclerosis. One group (30 patients) received prednisolone in the complex treatment while the second group (30 patients) received only complex treatment. A control group of 20 healthy persons was examined. Patients of the first group showed marked neurological and immunological disorders which is considered as a complication due to the empiric prednisolone doses.","PeriodicalId":23717,"journal":{"name":"Vrachebnoe delo","volume":" 12","pages":"61-3"},"PeriodicalIF":0.0000,"publicationDate":"1991-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone].\",\"authors\":\"A A Iarosh, A M Tiazhkorob, M M Prokopiv, S A Kanevskaia, I K Zhovnir\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The authors examined clinically and immunologically 60 patients with multiple sclerosis. One group (30 patients) received prednisolone in the complex treatment while the second group (30 patients) received only complex treatment. A control group of 20 healthy persons was examined. Patients of the first group showed marked neurological and immunological disorders which is considered as a complication due to the empiric prednisolone doses.\",\"PeriodicalId\":23717,\"journal\":{\"name\":\"Vrachebnoe delo\",\"volume\":\" 12\",\"pages\":\"61-3\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1991-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vrachebnoe delo\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vrachebnoe delo","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

作者对60例多发性硬化症患者进行了临床和免疫学检查。一组(30例)采用强的松龙综合治疗，另一组(30例)仅采用综合治疗。对照组为20名健康人。第一组患者表现出明显的神经和免疫紊乱，这被认为是由于经验泼尼松龙剂量引起的并发症。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

[Changes in the clinical and immunological indices of patients with disseminated sclerosis being treated with prednisolone].

The authors examined clinically and immunologically 60 patients with multiple sclerosis. One group (30 patients) received prednisolone in the complex treatment while the second group (30 patients) received only complex treatment. A control group of 20 healthy persons was examined. Patients of the first group showed marked neurological and immunological disorders which is considered as a complication due to the empiric prednisolone doses.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Vrachebnoe delo

自引率

0.00%

发文量